12 October 2017
Stable long-term investment in medical research is vital for the development of new treatments and also generates economic benefits for the UK.
- Long-term government investment in research through the dual support system is needed to underpin the UK’s vibrant science base. It allows scientists to access a diverse mix of funding and respond to new challenges and opportunities.
- The Charity Research Support Fund (CRSF), distributed by the Higher Education Funding Council for England (HEFCE), supports world-class universities in England and enables public donations to be spent directly on research.
- AMRC and our members are calling on Government to enhance the CRSF in real terms in line with inflation and charity investment, as recommended in the Life Sciences Industrial Strategy.
- It is vital that new funds for research are allocated in line with the ‘balanced funding principle’ between both challenge-led funding and university block funding in order to ensure optimal functioning of the research landscape.
Quality and standards
- Where medical research charities fund in collaboration with others the resulting research is often exceptionally high impact, involving international co-authors.
- Charities want to maximise the impact of every pound they spend. Many use tools like Researchfish to track outcomes and inform future strategy.
Data and impact
- Medical research is the UK’s favourite charitable cause; in 2016 over 8 million people donated to medical research.
- Since 2008, medical research charities have invested nearly £11 billion in UK universities. The UK is second only to the US for the size of its charity research-funding sector.
- Our case studies and data demonstrate the value of charity investment in UK research. Every £1 of public or charity investment in medical research generates monetised health benefits of 7-10p each year, forever, as well as 15-18p of additional spill over benefits in the wider economy.